W. Franklin

1.1k total citations
28 papers, 868 citations indexed

About

W. Franklin is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, W. Franklin has authored 28 papers receiving a total of 868 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Pulmonary and Respiratory Medicine, 11 papers in Oncology and 6 papers in Molecular Biology. Recurrent topics in W. Franklin's work include Lung Cancer Treatments and Mutations (15 papers), Lung Cancer Diagnosis and Treatment (7 papers) and Cancer Genomics and Diagnostics (4 papers). W. Franklin is often cited by papers focused on Lung Cancer Treatments and Mutations (15 papers), Lung Cancer Diagnosis and Treatment (7 papers) and Cancer Genomics and Diagnostics (4 papers). W. Franklin collaborates with scholars based in United States, United Kingdom and Japan. W. Franklin's co-authors include Francis C. Lowell, Marileila Varella‐Garcia, Richard W. Erickson, Woodruff Emlen, Lynne Bemis, William A. Robinson, Eri Nakajima, Fred R. Hirsch, H. Kato and B. Helfrich and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Annals of Internal Medicine.

In The Last Decade

W. Franklin

28 papers receiving 805 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
W. Franklin United States 14 456 321 298 224 59 28 868
Sven Gogov Switzerland 12 409 0.9× 294 0.9× 351 1.2× 145 0.6× 36 0.6× 25 804
Yoshimi Otani Japan 11 281 0.6× 168 0.5× 153 0.5× 73 0.3× 110 1.9× 38 574
R. Pieters Netherlands 23 232 0.5× 611 1.9× 303 1.0× 109 0.5× 43 0.7× 41 1.8k
Marie O’Donnell United Kingdom 13 385 0.8× 474 1.5× 104 0.3× 236 1.1× 106 1.8× 38 828
Yasuro Fukuyama Japan 17 592 1.3× 728 2.3× 447 1.5× 180 0.8× 138 2.3× 41 1.4k
Masayuki Iwazaki Japan 15 358 0.8× 156 0.5× 199 0.7× 75 0.3× 170 2.9× 92 718
Tateki Yoshino Japan 14 458 1.0× 208 0.6× 185 0.6× 90 0.4× 257 4.4× 35 863
V.J. Harvey New Zealand 11 176 0.4× 226 0.7× 319 1.1× 77 0.3× 127 2.2× 24 678
Morio Ohta Japan 9 598 1.3× 135 0.4× 417 1.4× 101 0.5× 161 2.7× 28 875

Countries citing papers authored by W. Franklin

Since Specialization
Citations

This map shows the geographic impact of W. Franklin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W. Franklin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W. Franklin more than expected).

Fields of papers citing papers by W. Franklin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W. Franklin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W. Franklin. The network helps show where W. Franklin may publish in the future.

Co-authorship network of co-authors of W. Franklin

This figure shows the co-authorship network connecting the top 25 collaborators of W. Franklin. A scholar is included among the top collaborators of W. Franklin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W. Franklin. W. Franklin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Weiss, Glen J., Lynne Bemis, Eri Nakajima, et al.. (2008). EGFR regulation by microRNA in lung cancer: correlation with clinical response and survival to gefitinib and EGFR expression in cell lines. Annals of Oncology. 19(6). 1053–1059. 193 indexed citations
2.
Dziadziuszko, Rafał, Fred R. Hirsch, Marileila Varella‐Garcia, et al.. (2007). Epidermal growth factor receptor (EGFR) immunohistochemistry: Comparison of antibodies (Abs) and cut points to predict benefit from gefitinib in a phase III placebo-controlled study in advanced non-small cell lung cancer (NSCLC). Journal of Clinical Oncology. 25(18_suppl). 7576–7576. 4 indexed citations
3.
Hesketh, Paul J., Kari Chansky, Primo N. Lara, et al.. (2007). Erlotinib as initial therapy in patients with advanced non-small cell lung cancer (NSCLC) and a performance status (PS) of 2: A SWOG phase II trial (S0341). Journal of Clinical Oncology. 25(18_suppl). 7536–7536. 9 indexed citations
4.
Dziadziuszko, Rafał, Bente Holm, Kell Østerlind, et al.. (2006). Epidermal growth factor receptor gene copy number and protein level are not associated with outcome of non-small-cell lung cancer patients treated with chemotherapy. Annals of Oncology. 18(3). 447–452. 37 indexed citations
5.
Terai, Yohey, et al.. (2006). Somatic mutation in the EGFR gene in ovarian carcinoma detected by SSCP and direct sequencing. Journal of Clinical Oncology. 24(18_suppl). 5063–5063. 1 indexed citations
6.
Cappuzzo, Federico, Luca Toschi, Rocco Trisolini, et al.. (2006). Clinical and biological effects of gefitinib in EGFR FISH positive/phospho-akt positive or never smoker non-small cell lung cancer (NSCLC): Preliminary results of the ONCOBELL trial. Journal of Clinical Oncology. 24(18_suppl). 7023–7023. 12 indexed citations
7.
Cappuzzo, Federico, Marileila Varella‐Garcia, Luca Toschi, et al.. (2005). O-191 HER1-HER2-HER3 gene amplification and akt activation inpatients with advanced non-small cell lung cancer (NSCLC) treated with gefitinib. Lung Cancer. 49. S63–S64. 1 indexed citations
8.
Hirsch, W., J. McCoy, Federico Cappuzzo, et al.. (2005). O-107 FISH and Immunohistochemistry (IHC) can be used to selectNSCLC patients, who will not benefit from gefitinib treatment. Lung Cancer. 49. S38–S38. 9 indexed citations
9.
Gumerlock, Paul H., William Holland, W. Franklin, et al.. (2005). Mutational analysis of K-RAS and EGFR implicates K-RAS as a resistance marker in the Southwest Oncology Group (SWOG) trial S0126 of bronchioalveolar carcinoma (BAC) patients (pts) treated with gefitinib. Journal of Clinical Oncology. 23(16_suppl). 7008–7008. 30 indexed citations
10.
West, Howard, W. Franklin, Paul H. Gumerlock, et al.. (2004). Gefitinib (ZD1839) therapy for advanced bronchioloalveolar lung cancer (BAC): Southwest Oncology Group (SWOG) Study S0126. Journal of Clinical Oncology. 22(14_suppl). 7014–7014. 8 indexed citations
11.
Franklin, W., Kari Chansky, Paul H. Gumerlock, et al.. (2004). Association between activation of ErbB pathway genes and survival following gefitinib treatment in advanced BAC (SWOG 0126). Journal of Clinical Oncology. 22(14_suppl). 7015–7015. 19 indexed citations
12.
Franklin, W., et al.. (2002). Epidermal growth factor receptor expression, signal pathway, and inhibitors in non–small cell lung cancer. Seminars in Oncology. 29(5). 38–44. 116 indexed citations
13.
14.
Greenfield, David S., W. Franklin, R. Weslie Tyson, Roger Giller, & Elizabeth J. Shpall. (1996). #676 CD34 expression on pediatric solid tumors. Journal of Pediatric Hematology/Oncology. 18(4). 464–464. 2 indexed citations
15.
Erickson, Richard W., W. Franklin, & Woodruff Emlen. (1994). Treatment of hemorrhagic lupus pneumonitis with plasmapheresis. Seminars in Arthritis and Rheumatism. 24(2). 114–123. 56 indexed citations
16.
Shpall, Elizabeth J., Roy B. Jones, SI Bearman, et al.. (1994). Transplantation of CD34+ marrow and/or PBPCS into breast cancer patients following high-dose chemotherapy. Bone Marrow Transplantation. 14. 1 indexed citations
17.
Cohn, Susan L., et al.. (1990). Analysis of DNA ploidy and proliferative activity in relation to histology and N-myc amplification in neuroblastoma.. PubMed. 136(5). 1043–52. 45 indexed citations
18.
Franklin, W. & Francis C. Lowell. (1961). UNRECOGNIZED AIRWAY OBSTRUCTION ASSOCIATED WITH SMOKING: A PROBABLE FORERUNNER OF OBSTRUCTIVE PULMONARY EMPHYSEMA. Annals of Internal Medicine. 54(3). 379–386. 40 indexed citations
19.
Franklin, W., Francis C. Lowell, Alan L. Michelson, & Irving W. Schiller. (1956). CHRONIC OBSTRUCTIVE PULMONARY EMPHYSEMA: A DISEASE OF SMOKERS. Annals of Internal Medicine. 45(2). 268–274. 59 indexed citations
20.
Franklin, W., et al.. (1953). INSULIN-RESISTANT DIABETES MELLITUS ASSOCIATED WITH HEMOCHROMATOSIS. Annals of Internal Medicine. 38(6). 1295–1306. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sven Gogov Breakdown of academic impact, for papers by Yoshimi Otani Breakdown of academic impact, for papers by R. Pieters Breakdown of academic impact, for papers by Marie O’Donnell Breakdown of academic impact, for papers by Yasuro Fukuyama Breakdown of academic impact, for papers by Masayuki Iwazaki Breakdown of academic impact, for papers by Tateki Yoshino Breakdown of academic impact, for papers by V.J. Harvey Breakdown of academic impact, for papers by Morio Ohta
Rankless by CCL
2026